Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) EBT (2020 - 2025)

Stemtech (STEK) has disclosed EBT for 6 consecutive years, with -$812541.0 as the latest value for Q3 2025.

  • Quarterly EBT rose 30.64% to -$812541.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$3.0 million through Sep 2025, up 43.43% year-over-year, with the annual reading at -$3.8 million for FY2024, 30.55% up from the prior year.
  • EBT hit -$812541.0 in Q3 2025 for Stemtech, down from -$296280.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of $17.4 million in Q3 2022 to a low of -$25.0 million in Q2 2022.
  • Historically, EBT has averaged -$1.4 million across 5 years, with a median of -$812541.0 in 2025.
  • Biggest YoY gain for EBT was 426.83% in 2022; the steepest drop was 3129.07% in 2022.
  • Year by year, EBT stood at -$848155.0 in 2021, then skyrocketed by 47.4% to -$446114.0 in 2022, then crashed by 317.83% to -$1.9 million in 2023, then surged by 78.72% to -$396580.0 in 2024, then tumbled by 104.89% to -$812541.0 in 2025.
  • Business Quant data shows EBT for STEK at -$812541.0 in Q3 2025, -$296280.0 in Q2 2025, and -$1.5 million in Q1 2025.